These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 8703669

  • 1. Lack of an effect of nefazodone on the pharmacokinetics and pharmacodynamics of theophylline during concurrent administration in patients with chronic obstructive pulmonary disease.
    Dockens RC, Rapoport D, Roberts D, Greene DS, Barbhaiya RH.
    Br J Clin Pharmacol; 1995 Dec; 40(6):598-601. PubMed ID: 8703669
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the steady-state pharmacokinetics of nefazodone after administration of 200 mg twice daily or 400 mg once daily in the morning or evening.
    Marathe PH, Lee JS, Greene DS, Barbhaiya RH.
    Br J Clin Pharmacol; 1996 Jan; 41(1):21-7. PubMed ID: 8824689
    [Abstract] [Full Text] [Related]

  • 3. Pharmacodynamics, pharmacokinetics and safety of revefenacin (TD-4208), a long-acting muscarinic antagonist, in patients with chronic obstructive pulmonary disease (COPD): Results of two randomized, double-blind, phase 2 studies.
    Quinn D, Barnes CN, Yates W, Bourdet DL, Moran EJ, Potgieter P, Nicholls A, Haumann B, Singh D.
    Pulm Pharmacol Ther; 2018 Feb; 48():71-79. PubMed ID: 28987804
    [Abstract] [Full Text] [Related]

  • 4. Coadministration of nefazodone and benzodiazepines: II. A pharmacokinetic interaction study with triazolam.
    Barbhaiya RH, Shukla UA, Kroboth PD, Greene DS.
    J Clin Psychopharmacol; 1995 Oct; 15(5):320-6. PubMed ID: 8830062
    [Abstract] [Full Text] [Related]

  • 5. Absence of a pharmacokinetic interaction between intravenous theophylline and orally administered levofloxacin.
    Gisclon LG, Curtin CR, Fowler CL, Williams RR, Hafkin B, Natarajan J.
    J Clin Pharmacol; 1997 Aug; 37(8):744-50. PubMed ID: 9378847
    [Abstract] [Full Text] [Related]

  • 6. Coadministration of nefazodone and benzodiazepines: III. A pharmacokinetic interaction study with alprazolam.
    Greene DS, Salazar DE, Dockens RC, Kroboth P, Barbhaiya RH.
    J Clin Psychopharmacol; 1995 Dec; 15(6):399-408. PubMed ID: 8748428
    [Abstract] [Full Text] [Related]

  • 7. Lack of interaction between nefazodone and cimetidine: a steady state pharmacokinetic study in humans.
    Barbhaiya RH, Shukla UA, Greene DS.
    Br J Clin Pharmacol; 1995 Aug; 40(2):161-5. PubMed ID: 8562300
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Investigation of pharmacokinetic and pharmacodynamic interactions after coadministration of nefazodone and haloperidol.
    Barbhaiya RH, Shukla UA, Greene DS, Breul HP, Midha KK.
    J Clin Psychopharmacol; 1996 Feb; 16(1):26-34. PubMed ID: 8834415
    [Abstract] [Full Text] [Related]

  • 10. Safety, tolerance, and preliminary pharmacokinetics of nefazodone after administration of single and multiple oral doses to healthy adult male volunteers: a double-blind, phase I study.
    Barbhaiya RH, Marathe PH, Greene DS, Mayol RF, Shukla UA, Gammans RR, Pittman KA, Robinson D.
    J Clin Pharmacol; 1995 Oct; 35(10):974-84. PubMed ID: 8568015
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of alosetron on theophylline pharmacokinetics.
    Koch KM, Ricci BM, Hedayetullah NS, Jewell D, Kersey KE.
    Br J Clin Pharmacol; 2001 Nov; 52(5):596-600. PubMed ID: 11736869
    [Abstract] [Full Text] [Related]

  • 13. Inhaled salmeterol: a review of its efficacy in chronic obstructive pulmonary disease.
    Jarvis B, Markham A.
    Drugs Aging; 2001 Nov; 18(6):441-72. PubMed ID: 11419918
    [Abstract] [Full Text] [Related]

  • 14. Nonlinear pharmacokinetics of nefazodone after escalating single and multiple oral doses.
    Kaul S, Shukla UA, Barbhaiya RH.
    J Clin Pharmacol; 1995 Aug; 35(8):830-9. PubMed ID: 8522641
    [Abstract] [Full Text] [Related]

  • 15. Assessment of pharmacokinetic and pharmacodynamic drug interactions between nefazodone and digoxin in healthy male volunteers.
    Dockens RC, Greene DS, Barbhaiya RH.
    J Clin Pharmacol; 1996 Feb; 36(2):160-7. PubMed ID: 8852392
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacokinetic and pharmacodynamic evaluation during coadministration of nefazodone and propranolol in healthy men.
    Salazar DE, Marathe PH, Fulmor IE, Lee JS, Raymond RH, Uderman HD.
    J Clin Pharmacol; 1995 Nov; 35(11):1109-18. PubMed ID: 8626885
    [Abstract] [Full Text] [Related]

  • 19. Loratadine and terfenadine interaction with nefazodone: Both antihistamines are associated with QTc prolongation.
    Abernethy DR, Barbey JT, Franc J, Brown KS, Feirrera I, Ford N, Salazar DE.
    Clin Pharmacol Ther; 2001 Mar; 69(3):96-103. PubMed ID: 11240972
    [Abstract] [Full Text] [Related]

  • 20. Value of theophylline treatment in patients handicapped by chronic obstructive lung disease.
    McKay SE, Howie CA, Thomson AH, Whiting B, Addis GJ.
    Thorax; 1993 Mar; 48(3):227-32. PubMed ID: 8497820
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.